Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2314636
Max Phase: Preclinical
Molecular Formula: C30H40Cl2N2O2S2
Molecular Weight: 524.80
Molecule Type: Small molecule
Associated Items:
ID: ALA2314636
Max Phase: Preclinical
Molecular Formula: C30H40Cl2N2O2S2
Molecular Weight: 524.80
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1c(CCO)sc[n+]1CCCCc1ccc(CCCC[n+]2csc(CCO)c2C)c2ccccc12.[Cl-].[Cl-]
Standard InChI: InChI=1S/C30H40N2O2S2.2ClH/c1-23-29(15-19-33)35-21-31(23)17-7-5-9-25-13-14-26(28-12-4-3-11-27(25)28)10-6-8-18-32-22-36-30(16-20-34)24(32)2;;/h3-4,11-14,21-22,33-34H,5-10,15-20H2,1-2H3;2*1H/q+2;;/p-2
Standard InChI Key: GEEVLFVFSUCSIR-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 524.80 | Molecular Weight (Monoisotopic): 524.2520 | AlogP: 5.27 | #Rotatable Bonds: 14 |
Polar Surface Area: 48.22 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -1.34 | CX LogD: -1.34 |
Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.17 | Np Likeness Score: 0.07 |
1. Caldarelli SA, El Fangour S, Wein S, Tran van Ba C, Périgaud C, Pellet A, Vial HJ, Peyrottes S.. (2013) New bis-thiazolium analogues as potential antimalarial agents: design, synthesis, and biological evaluation., 56 (2): [PMID:23289711] [10.1021/jm3014585] |
Source(1):